Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible staphylococcus aureus bacteraemia: A propensity-score adjusted retrospective cohort study

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 2, 2014, Pages 506-514

  Rasmussen, Jon Bjarke ^a   Knudsen, Jenny Dahl ^a   Arpi, Magnus ^a   Schønheyder, Henrik Carl ^b   Benfield, Thomas ^a,c   Østergaard, Christian ^a  

^a Mental Health Center Glostrup   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

lactams; S. aureus; Sepsis; Septicaemia epidemiology

Indexed keywords

CARBAPENEM; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; DICLOXACILLIN; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BONE INFECTION; COHORT ANALYSIS; DEMOGRAPHY; DENMARK; DEVICE INFECTION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE INFECTION; PROPENSITY SCORE; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; URINARY TRACT INFECTION;

S. AUREUS; SEPSIS; SEPTICAEMIA EPIDEMIOLOGY; Β-LACTAMS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CEFUROXIME; COHORT STUDIES; DICLOXACILLIN; FEMALE; HUMANS; MALE; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 84892458680     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt375     Document Type: Article

References (15)

1. Thwaites GE, Edgeworth JD, Gkrania-Klotsas E et al. Clinicalmanagement of Staphylococcus aureus bacteraemia. Lancet Infect Dis 2011; 11: 208-22.
2. Laupland KB, Lyytikäinen O, SøgaardMet al. The changing epidemiology of Staphylococcus aureus bloodstreaminfection: amultinationalpopulationbased surveillance study. Clin Microbiol Infect 2013; 19: 465-71.
3. Nissen JL, Skov R, Knudsen JD et al. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case- control and cohort analysis. J Antimicrob Chemother 2013; 68: 1894-900.
4. Paul M, Zemer-Wassercug N, Talker O et al. Are all β-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?. Clin Microbiol Infect 2011; 17: 1581-6.
5. Psaty BM, Koepsell TD, Lin D et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999;47: 749-54.
6. Rosenbaum PR, Rubin DB. The central role of the propensity score inobservational studies for causal effects. Biometrika 1983; 70: 41-55.
7. Jarløv JO, Rosdahl VT. Quantitative determination of β-lactamase production in Staphylococcus aureus strains compared to qualitative testing by a microbiological clover leaf test, a chromogenic cephalosporin test and an iodometric test. Acta Pathol Microbiol Immunol Scand B 1986;94: 415-21.
8. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39 Suppl: 30-3.
9. Friedman ND, Kaye KS, Stout JE et al. Health care-associatedbloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-7.
10. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
11. Rhee JY, Kwon KT, Ki HK et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 2009; 31: 146-50.
12. Coca-Perraillon M. Local and Global Optimal Propensity Score Matching. SAS Global Forum 2007: Statistics and Data Analysis, 2007; 1-9.
13. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011; 10: 150-61.
14. Lévesque LE, Hanley JA, Kezouh A et al. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010; 340: b5087.
15. Leibovici L, Samra Z, Konigsberger H et al. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807-12.